World's Best Scientists 2026 revealed!
Carsten Müller-Tidow

Carsten Müller-Tidow

D-Index & Metrics

Medicine

D-Index
91
Citations
32081
World Ranking
11714
National Ranking
636

Carsten Müller-Tidow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carsten Müller-Tidow sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 712 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carsten Müller-Tidow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carsten Müller-Tidow sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carsten Müller-Tidow is affiliated with the University Hospital Heidelberg in Germany. Their research focuses primarily on fields within medicine, including extensive work in hematology, molecular biology, oncology, immunology, and genetics.

The scientist's recent published papers highlight key areas of interest and ongoing investigations:

  • Side-effect management of chimeric antigen receptor (CAR) T-cell therapy, 2020, Annals of Oncology
  • CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity, 2021, Blood
  • The pre-existing T cell landscape determines the response to bispecific T cell engagers in multiple myeloma patients, 2023, Cancer Cell
  • A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy, 2023, Nature Medicine
  • Single-cell proteo-genomic reference maps of the hematopoietic system enable the purification and massive profiling of precisely defined cell states, 2021, Nature Immunology

Frequent co-authors that have collaborated with Carsten Müller-Tidow include:

  • Hubert Serve
  • Peter Dreger
  • Christoph Röllig
  • Uwe Platzbecker
  • Claudia D. Baldus

Publication venues where their work appears recurrently include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • HemaSphere
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia

The scientist's research integrates several major topics within their fields of study:

  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Immune Cell Function and Interaction

Within the subfields, Carsten Müller-Tidow's work spans:

  • Hematology
  • Molecular Biology
  • Oncology
  • Immunology
  • Genetics

Their studies have contributed to understanding the management of CAR T-cell therapies, immune cell interactions, and advances in leukemia and myeloma treatments. Their interdisciplinary approach merges clinical and molecular perspectives, supporting progress in personalized medicine approaches to hematologic malignancies.

Best Publications

  • MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer.

    Ping Ji;Sven Diederichs;Wenbing Wang;Sebastian Böing

  • Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

    Tino Schenk;Weihsu Claire Chen;Stefanie Göllner;Louise Howell

  • The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.

    Lars Henning Schmidt;Tilmann Spieker;Steffen Koschmieder;Julia Humberg

  • Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival

    Ashley Hamilton;G. Vignir Helgason;Mirle Schemionek;Bin Zhang

  • Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

    Christoph Röllig;Hubert Serve;Andreas Hüttmann;Richard Noppeney

  • Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.

    Chantana Polprasert;Isabell Schulze;Mikkael Sekeres;Hideki Makishima

  • Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

    Thomas Büchner;Wolfgang E. Berdel;Claudia Haferlach;Torsten Haferlach

  • Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells

    Carsten Müller-Tidow;Björn Steffen;Thomas Cauvet;Lara Tickenbrock

  • Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial

    Hubert Serve;Utz Krug;Ruth Wagner;M. Cristina Sauerland

  • Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes

    Chunaram Choudhary;Jesper V. Olsen;Jesper V. Olsen;Christian Brandts;Jürgen Cox

  • Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations

    Masao Mizuki;Joachim Schwäble;Joachim Schwäble;Joachim Schwäble;Claudia Steur;Claudia Steur;Claudia Steur;Chunaram Choudhary;Chunaram Choudhary;Chunaram Choudhary

  • EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

    Günther H. S. Richter;Stephanie Plehm;Annette Fasan;Sabine Rössler

  • Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages

    Daniel Baitsch;Hans H. Bock;Thomas Engel;Ralph Telgmann

  • Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia

    John A. Pulikkan;Viola Dengler;Philomina S. Peramangalam;Abdul A. Peer Zada

  • Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

    Utz Krug;Christoph Röllig;Anja Koschmieder;Achim Heinecke

  • Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.

    M.-L. Schubert;M. Schmitt;L. Wang;C.A. Ramos

  • AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations.

    Chunaram Choudhary;Joachim Schwäble;Joachim Schwäble;Christian Brandts;Christian Brandts;Lara Tickenbrock;Lara Tickenbrock

  • The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.

    Bryan Linggi;Carsten Müller-Tidow;Louis van de Locht;Ming Hu

  • Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation.

    Christian H. Brandts;Bülent Sargin;Miriam Rode;Christoph Biermann

  • EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation

    S Plehm;A Fasan;S Rössler;R Unland

Frequent Co-Authors

Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Hubert Serve
Hubert Serve Goethe University Frankfurt
Martin Dugas
Martin Dugas Heidelberg University
Hartmut Goldschmidt
Hartmut Goldschmidt University Hospital Heidelberg
Sven Diederichs
Sven Diederichs German Cancer Research Center
Daniel G. Tenen
Daniel G. Tenen National University of Singapore
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering other routes to a healthcare career? There are several online degree programs that can help you advance in the medical field—even for those who do not follow the traditional medical school path.

Many students choose nursing as an alternative, thanks to its flexible degree options and rewarding career prospects. If affordability is a top concern, check out what is the cheapest online college for nursing? to find programs that fit your budget.

Already an RN? Earning a BSN can boost your career and earning potential. Explore the cheapest rn to bsn online programs available if you’re looking for flexible and affordable advancement.

For those interested in research, teaching, or advanced clinical practice, numerous online phd programs in nursing offer a convenient pathway to the highest academic credentials in nursing.

Even non-nurses with a bachelor’s degree in another field can enter nursing. Review msn direct entry programs online to find fast-track options designed for career changers.

Each of these online pathways can help you join the healthcare workforce and make a difference, even if you don’t pursue a traditional MD.

Best Scientists Citing Carsten Müller-Tidow

Trending Scientists

Recently Published Articles